Press Release – New York, NY – December 21, 2022 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book running manager in the $8 Million underwritten …
Sichenzia Ross Ference LLP Represents Laidlaw & Company (UK) Ltd. in $2.3 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants of Amesite Inc.
Press Release – New York, NY – September 1, 2022 – Sichenzia Ross Ference LLP announced today that it represented Laidlaw & Company (UK) Ltd. as sole placement agent for Amesite Inc. (NASDAQ: …
Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in $100 Million At-The-Market Offering Facility
Press Release – New York, NY – April 14, 2022 – Sichenzia Ross Ference LLP announced today that it represented Relmada Therapeutics, Inc. (NASDAQ: “RLMD”), a late-stage biotechnology company, in a …
Sichenzia Ross Ference LLP Represents Biotricity, Inc. in $50 Million At-The-Market Offering Facility
Press Release – New York, NY – March 23, 2022 – Sichenzia Ross Ference LLP announced today that it represented Biotricity, Inc. (NASDAQ: “BTCY”), a medical diagnostic and consumer healthcare …
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $10 Million Underwritten Public Offering for Tantech Holdings Ltd.
Press Release – New York, NY – March 21, 2022 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of Tantech …
Sichenzia Ross Ference LLP Represents Alliance Global Partners as Financial Advisor in a $5.9 Million Warrant Exercise for ShiftPixy, Inc.
Press Release – New York, NY – January 31, 2022 – Sichenzia Ross Ference LLP today announced that it represented Alliance Global Partners (AGP), as the financial advisor for the warrant exercise for …
